{"id":"C1953A00072","name":"Therapeutic Substances Act 1953","slug":"therapeutic-substances-act-1953","collection":"act","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":"72 of 1953","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":4558,"registerId":"commonwealth-C1953A00072-current","compilationNumber":null,"startDate":"2026-03-30","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Substances Act 1953","content":"THERAPEUTIC SUBSTANCES.\n\nNo. 72 of 1953.\n\nAn Act to provide standards for certain Therapeutic Substances, and for other purposes.\n\n\\[Assented to 5th December, 1953.\\]\n\nBE it enacted by the Queen’s Most Excellent Majesty, the Senate, and the House of Representatives of the Commonwealth of Australia, as follows :—\n\nShort title.\n\n1. This Act may be cited as the Therapeutic Substances Act 1953.\n\n  \n\nCommencement.\n\n2. This Act shall come into operation on a date to be fixed by Proclamation.\n\nRepeal.\n\n3. The Therapeutic Substances Act 1937 and the Therapeutic Substances Act 1938 are repealed.\n\nInterpretation.\n\n4.—(1.) In this Act, unless the contrary intention appears—\n\n“controlled therapeutic substance” means a therapeutic substance—\n\n(a) which is the subject of a monograph in the British Pharmacopoeia or in the British Pharmaceutical Codex and is not specified in the regulations as a therapeutic substance which is not a controlled therapeutic substance; or\n\n(b) which is specified in the regulations as a controlled therapeutic substance;\n\n“official name”, in relation to a controlled therapeutic substance, means a name or title, or an abbreviation or synonym of a name or title, given or specified as a name or title, or as an abbreviation or synonym of a name or title, of the therapeutic substance in a monograph in the British Pharmacopoeia or the British Pharmaceutical Codex or in the regulations;\n\n“pharmaceutical benefit” means a drug, medicinal preparation or medicinal compound which is a pharmaceutical benefit for the purposes of a law of the Commonwealth relating to the provision of pharmaceutical benefits;\n\n“substance” includes a mixture or compound of substances;\n\n“the British Pharmaceutical Codex” means —\n\n(a) the latest edition for the time being of the book called the British Pharmaceutical Codex published by direction of the Council of the Pharmaceutical Society of Great Britain; or\n\n(b) if that edition has been added to or amended —that edition as affected by the additions or amendments;\n\n“the British Pharmacopoeia” means—\n\n(a) the latest edition (being an edition that has taken effect) for the time being of the book called the British Pharmacopoeia published under the direction of the General Medical Council of the United Kingdom; or\n\n(b) if that edition has been added to or amended by additions or amendments that have taken effect— that edition as affected by those additions or amendments;\n\n“therapeutic substance” means a substance which has a therapeutic use and includes a surgical ligature, suture or dressing, but does not include a vaccine prepared from microscopic organisms from the body of a person or animal for use in the treatment of that person or animal only;\n\n  \n\n“therapeutic use” means a use for the purpose of—\n\n(a) preventing, diagnosing, curing or alleviating of a disease, ailment, defect or injury in persons or animals;\n\n(b) influencing, inhibiting or modifying of a physiological process in persons or animals; or\n\n(c) testing of susceptibility to a disease or ailment in persons or animals;\n\n“the standard” means—\n\n(a) in relation to a therapeutic substance which is specified in the regulations as a controlled therapeutic substance—the standard constituted by the description of that substance in the regulations;\n\n(b) in relation to a therapeutic substance to which the last preceding paragraph does not apply but which is the subject of a monograph in the British Pharmacopoeia—the standard constituted by the statements in that monograph; and\n\n(c) in relation to a therapeutic substance to which neither of the last two preceding paragraphs applies but which is the subject of a monograph in the British Pharmaceutical Codex—the standard constituted by the statements in that monograph.\n\n(2.) For the purposes of this Act, goods shall be deemed to be represented to consist of a controlled therapeutic substance—\n\n(a) if the goods bear a name or description—\n\n(i) which is, or is likely to be taken for, an official name of that controlled therapeutic substance; or\n\n(ii) which is likely to cause the goods to be taken to consist of that controlled therapeutic substance; or\n\n(b) if the goods are otherwise represented, by writing or otherwise, to consist of that controlled therapeutic substance.\n\n(3.) For the purposes of this Act, goods shall be deemed to bear a name, description or other particulars if that name or description or those particulars are set out on, or on a label affixed or attached to, the goods or a container or package containing the goods.\n\nReputations may modify monographs.\n\n5. The regulations may provide that a monograph in the British Pharmacopoeia or the British Pharmaceutical Codex shall, for the purposes of this Act. be deemed to be modified in accordance with the regulations.\n\nRegulations may provide for packaging and labelling.\n\n6. The regulations may provide that, for the purposes of a provision of this Act, any goods that consist of a controlled therapeutic substance shall be packed and labelled as provided in the regulations and, for the purposes of that provision, goods consisting of that therapeutic substance that are not packed and labelled as so provided shall be deemed not to conform to the standard for that therapeutic substance.\n\n  \n\nImportation of therapeutic substances.\n\n7.—(1.) The importation into Australia is prohibited of—\n\n(a) goods that consist of a therapeutic substance but do not bear—\n\n(i) a name or description that is an accepted scientific or technical name or description of the substance, or a name or description that indicates the composition of the substance; and\n\n(ii) particulars of the name and address of the manufacturer of the goods;\n\n(b) goods that consist of a controlled therapeutic substance but do not bear a name that is an official name of that controlled therapeutic substance and. if the controlled therapeutic substance has an official name in the English language, is in that language; and\n\n(c) goods that consist of, or are represented to consist of, a controlled therapeutic substance but do not conform to the standard for that controlled therapeutic substance or do not bear—\n\n(i) particulars of the quantity, by volume or weight, of the goods; and\n\n(ii) such other particulars as are prescribed.\n\n(2.) Goods the importation of which is prohibited under the last preceding sub-section are prohibited imports for the purposes of the Customs Act 1901-1953, and the provisions of that Act relating to prohibited imports apply accordingly.\n\nExemptions where importation is for scientific purposes or in public interest.\n\n8.—(1.) Where the Minister is satisfied that a person is engaged in scientific research, he may, by instrument in writing and subject to such conditions, if any, as are specified in the instrument, exempt from the last preceding section the importation of goods by that person for the purposes of scientific research.\n\n(2.) Where the Minister is satisfied that, in the public interest, it is proper for him so to do, he may, by instrument in writing and subject to such conditions, if any, as are specified in the instrument, exempt from the last preceding section the importation of goods specified in the instrument by a person specified in the instrument.\n\n(3.) Where a condition specified in an instrument of exemption issued under this section is not complied with, the person in whose favour the exemption was granted shall be deemed to have committed an offence against this Act.\n\nInterstate trade.\n\n9.—(1.) A person shall not, without the consent in writing of the Minister, cause, suffer or permit goods that consist of a therapeutic substance to become the subject of trade or commerce among the States unless—\n\n(a) the goods bear—\n\n(i) a name or description that is an accepted scientific or technical name or description of the substance, or a name or description that indicates the composition of the substance; and\n\n(ii) particulars of the name and address of the manufacturer of the goods;\n\n  \n\n(b) in the case of goods that consist of a controlled therapeutic substance, they bear a name that is an official name of that controlled therapeutic substance and, if the controlled therapeutic substance has an official name in the English language, is in that language; and\n\n(c) in the case of goods that consist of, or are represented to consist of, a controlled therapeutic substance, they conform to the standard for that controlled therapeutic substance and bear—\n\n(i) particulars of the quantity, by volume or weight, of the goods; and\n\n(ii) such other particulars as are prescribed.\n\n(2.) The consent of the Minister under the last preceding subsection may be given either unconditionally or subject to conditions.\n\n(3.) Where a condition subject to which a consent is given under this section is not complied with, the person to whom the consent was given shall be deemed to have committed an offence against this Act.\n\nStandards of pharmaceutical benefits.\n\n10.—(1.) Where a pharmaceutical benefit is a controlled therapeutic substance, a person shall not supply goods as that pharmaceutical benefit under a law of the Commonwealth relating to the provision of pharmaceutical benefits unless the goods conform to the standard for that controlled therapeutic substance.\n\n(2.) Where an ingredient in a pharmaceutical benefit is a controlled therapeutic substance, a person shall not supply goods as that pharmaceutical benefit under a law of the Commonwealth relating to the provision of pharmaceutical benefits if, in the preparation of those goods, there has been used, in lieu of that ingredient, a substance which does not conform to the standard for that controlled therapeutic substance.\n\n(3.) Where a person supplies goods as a pharmaceutical benefit under a law of the Commonwealth relating to the provision of pharmaceutical benefits in contravention of this section, that supply shall, for the purposes of that law, be deemed not to be a supply of a pharmaceutical benefit in accordance with that law.\n\nTherapeutic substances supplied to the Commonwealth.\n\n11. A person shall not supply to the Commonwealth or to an authority of the Commonwealth or of a Territory of the Commonwealth goods which consist of, or are represented to consist of, a controlled therapeutic substance unless the goods conform to the standard for that controlled therapeutic substance.\n\nExemptions in respect of goods not to be used for therapeutic purposes.\n\n12.—(1.) Where the Minister, or a person authorized by the Minister to grant exemptions under this section, is satisfied that goods are not intended for a therapeutic use, he may, by instrument in writing and subject to such conditions, if any, as are specified in the instrument—\n\n(a) exempt from section seven of this Act the importation of those goods by a person specified in the instrument; or\n\n  \n\n(b) exempt a person specified in the instrument from compliance with section nine or eleven of this Act in respect of those goods.\n\n(2.) Where a condition specified in an instrument of exemption issued under this section is not complied with, the person in whose favour the exemption was granted shall be deemed to have committed an offence against this Act.\n\nRegulations may provide for of relation examination, testing and analysing of therapeutic substances.\n\n13.—(1.) The regulations may make provision for or in relation to the examination, testing and analysing of goods to which this section applies.\n\n(2.) Without limiting the generality of the last preceding subsection, the regulations which may be made by virtue of that subsection include regulations making provision—\n\n(a) for or in relation to the taking of samples of goods to which this section applies;\n\n(b) for or in relation to the authorization of persons to take, and to enter upon premises for the purposes of taking, samples of goods to which this section applies and to make examinations and inquiries with respect to matters relating to goods to which this section applies;\n\n(c) for prescribing tests for the purpose of ascertaining whether goods conform to a standard;\n\n(d) for or in relation to the appointment or establishment of laboratories for the examination, testing and analysing of goods to which this section applies;\n\n(e) for the issue of certificates by persons who have examined, tested or analysed goods to which this section applies; and\n\n(f) for prescribing the extent to which certificates issued under the regulations are evidence of matters stated in the certificates.\n\n(3.) The goods to which this section applies are goods that consist of a therapeutic substance, being goods—\n\n(a) which are imported into Australia;\n\n(b) which are proposed to be exported from Australia;\n\n(c) which have been, are or are proposed to be, the subject of trade or commerce among the States;\n\n(d) which have been supplied as a pharmaceutical benefit under a law of the Commonwealth relating to the provision of pharmaceutical benefits or are in the possession of a person who is an approved pharmaceutical chemist under such a law at premises in respect of which he is so approved; or\n\n(e) which have been supplied to the Commonwealth or to an authority of the Commonwealth or of a Territory of the Commonwealth or are in the possession of a person who is a party to a subsisting contract for the supply of therapeutic substances to the Commonwealth or to such an authority.\n\n  \n\nPunishment of offences.\n\n14.—(1.) A person who contravenes, or fails to comply with, a provision of this Act is guilty of an offence against this Act.\n\n(2.) An offence against this Act may be prosecuted either summarily or upon indictment, but an offender is not liable to be punished more than once in respect of the same offence.\n\n(3.) The punishment for an offence against this Act is—\n\n(a) if the offence is prosecuted summarily—a fine not exceeding One hundred pounds or imprisonment for a term not exceeding six months; or\n\n(b) if the offence is prosecuted upon indictment—a fine not exceeding Five hundred pounds or imprisonment for a term not exceeding one year.\n\n(4.) In addition to any other punishment, a court may, if it thinks fit, order the forfeiture of goods in respect of which an offence against this Act has been committed.\n\nCourts to take Judicial notice of British Pharmacopoeia and British Pharmaceutical Codex.\n\n15. All courts shall, for the purposes of proceedings arising under this Act, take judicial notice of the British Pharmacopoeia and the British Pharmaceutical Codex.\n\nDelegation.\n\n16.—(1.) The Minister may, in relation to a particular matter or class of matters, or to a part of the Commonwealth by writing under his hand, delegate to a. person all or any of his powers under this Act except this power of delegation, so that the delegated powers may be exercised by the delegate with respect to the matter or class of matters, or the part of the Commonwealth, specified in the instrument of delegation.\n\n(2.) A delegation under this section is revocable at will and does not prevent the exercise of a power by the Minister.\n\nAct and regulations not in derogation of other Commonwealth laws.\n\n17. The provisions of this Act and the regulations are in addition to, and do not derogate from the operation of, any other law of the Commonwealth.\n\nEmergency quarantine measures.\n\n18.—(1.) Where the Governor-General is satisfied that a therapeutic substance, or the use of a therapeutic substance —\n\n(a) is causing, or is likely to cause, the occurrence in Australia of a serious outbreak of disease in persons or animals; or\n\n(b) is endangering, or is likely to endanger, the life or health of persons or animals in Australia,\n\nthe Governor-General may, by Proclamation, declare that quarantine measures are necessary in relation to that therapeutic substance.\n\n(2.) Where a Proclamation is in force under the last preceding sub-section in relation to a therapeutic substance, the Minister may, by order in writing, direct the person or persons to whom the order applies—\n\n(a) to destroy, or to refrain from selling or distributing, any of that therapeutic substance which is in his or their possession; or\n\n(b) not to prepare that therapeutic substance.\n\n  \n\n(3.) An order may be expressed to apply to persons generally, to persons included in a class of persons specified in the order or to a person specified in the order.\n\n(4.) An order does not take effect—\n\n(a) in the case of an order expressed to apply to a person specified in the order—until the order has been served on that person either personally or by sending it by post to, or by leaving it at, his last-known address; and\n\n(b) in any other case—until a copy of the order has been published in the Gazette.\n\n(5.) A person to whom an order applies shall comply with the directions in that order.\n\nRegulations.\n\n19. The Governor-General may make regulations, not inconsistent with this Act, prescribing all matters which by this Act are required or permitted to be prescribed, or which are necessary or convenient to be prescribed for carrying out or giving effect to this Act, and in particular—\n\n(a) for describing, by reference to composition, strength, potency, stability, sterility, quantity, quality or method of preparation, a. therapeutic substance that is specified in the regulations to be a controlled therapeutic substance;\n\n(b) for making provision for or in relation to—\n\n(i) the establishment of committees to advise the Minister on matters relating to the importation into Australia of therapeutic substances and on such other matters as are prescribed, and the functions and powers of those committees; and\n\n(ii) the payment of remuneration and allowances to members of committees established under the regulations; and\n\n(c) for prescribing penalties not exceeding a fine of One hundred pounds or imprisonment for six months for offences against the regulations.","sortOrder":0}],"analysis":{"summary":{"complexity_score":5,"scope_assessment":{"changed":false,"description":"This Act is a direct replacement of the Therapeutic Substances Act 1937 and the Therapeutic Substances Act 1938 (which it expressly repeals). It consolidates and modestly extends the earlier framework — adding emergency quarantine powers (s 18) and more detailed provisions around pharmaceutical benefits — but its core purpose remains unchanged: setting quality and labelling standards for therapeutic substances in trade and government supply. There is no evidence of significant scope creep beyond the original intent."},"complexity_factors":["Multiple layered definitions — 'controlled therapeutic substance', 'official name', 'the standard', 'therapeutic use', and 'the British Pharmacopoeia'/'British Pharmaceutical Codex' each have multi-part definitions with sub-clauses","The definition of 'the standard' has three cascading tiers (regulations → British Pharmacopoeia → British Pharmaceutical Codex), requiring the reader to work through each in sequence","Deeming provisions in ss 4(2) and 4(3) create legal fictions (goods are 'deemed' to be represented as a substance or to 'bear' particulars), adding interpretive complexity","Cross-references to external legislative frameworks — the Customs Act 1901-1953 and unspecified Commonwealth pharmaceutical benefits laws — require readers to consult multiple Acts","Conditional logic throughout (e.g. s 7 imports prohibition, s 9 interstate trade, s 10 pharmaceutical benefits) with multiple conjunctive and disjunctive conditions (a), (b), (c) that all must be satisfied","Dual prosecution pathway (summary vs indictment) with different penalty scales in s 14","Regulations play a significant role in defining key terms and standards, meaning the Act is incomplete without reference to subordinate legislation that isn't reproduced here","Emergency quarantine provisions in s 18 involve a two-stage trigger (Governor-General proclamation followed by Ministerial order) with separate service and publication requirements before orders take effect"],"plain_english_summary":"## Therapeutic Substances Act 1953 — Plain English Summary\n\n### What is this law about?\n\nThis Act sets **quality and labelling standards** for therapeutic substances — things like medicines, drugs, surgical stitches (sutures), and wound dressings — and controls how they can be imported, traded between States, and supplied to the Commonwealth Government or as taxpayer-funded medicines (called \"pharmaceutical benefits\").\n\n---\n\n### Who does it affect?\n\n- **Importers** of medicines and therapeutic products\n- **Manufacturers and suppliers** of medicines\n- **Pharmacists and chemists** who supply government-funded medicines\n- **Anyone selling therapeutic products** across State borders\n- **Businesses contracting** to supply medicines to the Commonwealth Government\n\n---\n\n### Key things the law does\n\n- **Defines \"controlled therapeutic substance\"**: This covers medicines listed in two authoritative British reference books — the *British Pharmacopoeia* and the *British Pharmaceutical Codex* (official scientific catalogues of medicines and their required standards) — as well as any substances added by government regulations.\n\n- **Sets labelling rules**: Goods containing therapeutic substances must clearly show:\n  - The scientific or technical name of the substance\n  - The manufacturer's name and address\n  - The quantity (by weight or volume)\n  - Any other details required by regulations\n  - The official name of the substance (if it's a \"controlled\" one)\n\n- **Bans non-compliant imports**: Medicines that don't meet labelling or quality standards cannot be legally imported into Australia. Goods that breach this rule become \"prohibited imports\" under customs law.\n\n- **Regulates interstate trade**: You can't send therapeutic substances across State lines unless they meet the same labelling and quality rules — unless the Minister gives written approval.\n\n- **Protects government medicine programs**: If a medicine is supplied as a government-funded \"pharmaceutical benefit,\" it must meet the required quality standard. If it doesn't, it's legally treated as though it was never supplied at all.\n\n- **Covers government supply contracts**: Anyone supplying medicines directly to the Commonwealth or a Territory government must also meet the quality standards.\n\n- **Allows testing and inspection**: Regulations can authorise people to take samples, enter premises, and test goods to check they meet the standards. Certificates from laboratories can be used as evidence in court.\n\n- **Emergency powers**: If a therapeutic substance is causing (or is likely to cause) a serious disease outbreak or poses a danger to people or animals, the Governor-General can declare a quarantine emergency. The Minister can then order people to **destroy stock, stop selling it, or stop making it altogether**.\n\n- **Ministerial exemptions**: The Minister can grant exemptions — for example, for scientific researchers or where public interest demands it — allowing non-compliant goods to be imported or traded. Breaching the conditions of an exemption is treated as an offence.\n\n- **Penalties**: Breaches can result in fines or imprisonment. Summary conviction (less serious court process) carries up to £100 fine or 6 months' jail. Indictable conviction (more serious court process) carries up to £500 fine or 12 months' jail. Courts can also order goods to be forfeited.\n\n- **Repeals old law**: This Act replaced two earlier versions of the same law from 1937 and 1938.\n\n---\n\n### Why does it matter?\n\nThis law is an early piece of **consumer protection and public health legislation**. Before laws like this, medicines could be sold with misleading labels, unknown ingredients, or dangerous quality. This Act ensures that if something is sold as a medicine, it actually *is* that medicine — made to a known standard, properly labelled, and safe to use. It also gives the government emergency powers to pull dangerous substances off the market quickly."},"issue_detection":{"absurdities":[{"type":"other","section":"Section 3","severity":"medium","reasoning":"In Australian statutory interpretation, a repeal provision in an uncommenced Act does not take effect until the Act commences. If Proclamation is indefinitely delayed, the 1937 and 1938 Acts continue in force. However, if Proclamation is eventually made, the repeal of 1937/38 Acts operates on the same date — meaning there is a non-trivial window of legal uncertainty and the risk of a gap in the regulatory regime if commencement is never proclaimed.","confidence":0.82,"description":"The Act repeals the Therapeutic Substances Act 1937 and 1938, but Section 2 provides that this Act only commences on a date fixed by Proclamation. If no Proclamation is ever made, the Act never commences — yet the repealing provision in Section 3 forms part of the same uncommenced Act. This creates the absurd possibility that the predecessor Acts are never repealed, yet the new Act also never operates."},{"type":"other","section":"Section 8(3)","severity":"medium","reasoning":"Section 14(1) creates offences for contraventions of 'a provision of this Act.' Conditions in an executive exemption instrument are not 'provisions of this Act.' The deeming in s8(3) is meant to bridge this gap, but it creates a situation where a purely ministerial, non-legislative condition — potentially not publicly gazetted, not subject to parliamentary scrutiny — triggers criminal liability. The same issue arises identically in ss 9(3) and 12(2). This is a structural absurdity rather than a mere drafting inelegance.","confidence":0.85,"description":"Breach of a condition in an exemption instrument causes the beneficiary to be 'deemed to have committed an offence against this Act.' This is a deemed offence with no specified fault element, no actus reus beyond a civil condition breach, and — critically — no penalty provision specifically applicable to it. The mechanism bypasses the usual requirement that an offence be constituted by a contravention of the Act itself under Section 14(1)."},{"type":"circular_definition","section":"Section 12(1)","severity":"medium","reasoning":"The Act regulates 'therapeutic substances,' defined by their therapeutic use. Section 12 exempts goods 'not intended for therapeutic use' from the importation and trade provisions. But those provisions only bite on goods that ARE therapeutic substances. A non-therapeutically-intended good is already outside the Act's scope without any exemption. The provision thus creates a bureaucratic process to exempt people from obligations they already don't have. Practically, one might argue the exemption targets goods that ARE therapeutic substances (by composition) but are being used for non-therapeutic purposes — but the Act's definition is use-based, not composition-based, making the overlap genuinely ambiguous.","confidence":0.75,"description":"The exemption power under Section 12 applies where the Minister is satisfied goods 'are not intended for a therapeutic use' — but the very definition of 'therapeutic substance' in Section 4(1) requires the substance to 'have a therapeutic use.' A substance with no therapeutic use cannot be a 'therapeutic substance' in the first place, meaning Sections 7, 9, and 11 would never apply to it. The exemption is therefore logically redundant: you cannot need an exemption from provisions that don't apply to you."},{"type":"other","section":"Section 15","severity":"medium","reasoning":"The definitions of 'the British Pharmacopoeia' and 'the British Pharmaceutical Codex' in Section 4(1) are ambulatory — they refer to the 'latest edition for the time being.' Combined with Section 15's judicial notice mandate, this means Australian courts must take judicial notice of a document whose content changes continuously and is determined entirely by a foreign private or quasi-public entity. Courts cannot practically take judicial notice of a document they may not have access to, whose latest edition may differ from edition to edition, and which has never been tabled in the Australian Parliament.","confidence":0.8,"description":"Courts are required to take judicial notice of the British Pharmacopoeia and the British Pharmaceutical Codex — foreign publications of a private body (the Pharmaceutical Society of Great Britain) and a UK statutory body (the General Medical Council). Judicial notice is a doctrine typically reserved for facts of common knowledge or domestic official documents. Mandating judicial notice of a living, continuously updated foreign private publication — where the 'latest edition' changes without parliamentary approval — effectively delegates the content of Australian law to a foreign private body."},{"type":"other","section":"Section 4(1) — definition of 'the standard'","severity":"low","reasoning":"If a substance appears in both the British Pharmacopoeia and the British Pharmaceutical Codex with different standards (a realistic scenario given these are distinct publications), the Act privileges the BP monograph (paragraph (b)) and ignores the BPC monograph entirely for that substance. This is a deliberate hierarchy, not an absurdity per se, but it is not disclosed to regulated parties in any transparent way, and a substance manufacturer consulting only the BPC would be unaware their goods are being judged against BP standards.","confidence":0.65,"description":"The definition of 'the standard' is structured as a cascade: paragraph (a) applies to substances specified in regulations; paragraph (b) applies to substances in the British Pharmacopoeia (but not paragraph (a)); paragraph (c) applies to substances in the British Pharmaceutical Codex (but not paragraphs (a) or (b)). However, the definition of 'controlled therapeutic substance' in the same section includes substances that appear in EITHER the BP or BPC. A substance could appear in BOTH the BP and BPC with different monographs, yet the standard cascade selects only one — without any mechanism to resolve conflicts between the two monographs."},{"type":"other","section":"Section 19(c)","severity":"low","reasoning":"While it is common for regulations to carry penalties, equating the regulatory maximum precisely with the statutory summary maximum blurs the hierarchy between primary and delegated legislation. More practically, Section 14(2) says a person 'is not liable to be punished more than once in respect of the same offence' — but if both an Act provision and a regulatory provision are breached by the same conduct, it is unclear whether these are the 'same offence,' potentially leaving prosecutors and courts without clear guidance.","confidence":0.7,"description":"Section 19(c) empowers the Governor-General to prescribe penalties in regulations 'not exceeding a fine of One hundred pounds or imprisonment for six months.' Section 14(3)(a) already prescribes exactly those same maximum penalties for summary offences against the Act itself. Regulations can therefore replicate but not exceed the Act's own summary penalties — making regulatory offences indistinguishable in severity from primary statutory offences, and creating potential double-jeopardy confusion if both a statutory and regulatory provision is contravened in the same conduct."}],"contradictions":[{"severity":"medium","section_a":"Section 7(1)(b)","section_b":"Section 7(1)(a)(i)","confidence":0.78,"description":"Section 7(1)(a)(i) requires goods to bear 'a name or description that is an accepted scientific or technical name or description of the substance, or a name or description that indicates the composition of the substance.' Section 7(1)(b) separately requires goods consisting of a controlled therapeutic substance to also bear 'a name that is an official name of that controlled therapeutic substance.' An official name (as defined in Section 4(1)) may be an abbreviation or synonym — which may not be an 'accepted scientific or technical name' nor indicate composition. A compliant label under (b) could simultaneously be non-compliant under (a)(i), and vice versa, since the two naming regimes are drawn from different sources (regulations/BP/BPC vs general scientific usage)."},{"severity":"medium","section_a":"Section 9(1)","section_b":"Section 17","confidence":0.65,"description":"Section 9(1) prohibits interstate trade in therapeutic substances without Ministerial consent UNLESS the conditions in paragraphs (a), (b), and (c) are met. Section 17 states the Act is 'in addition to, and does not derogate from,' other Commonwealth laws. Other Commonwealth laws — particularly trade and commerce legislation — may affirmatively protect the right to engage in interstate trade. Section 9(1)'s blanket prohibition with a ministerial consent carve-out could be read as impeding free interstate trade in a way that tensions with the constitutional basis of the provision (s51(i)) and contradicts the 'non-derogation' saving in Section 17, which arguably should prevent this Act from curtailing rights under other Commonwealth trade laws."},{"severity":"low","section_a":"Section 8(1) and 8(2)","section_b":"Section 12(1)","confidence":0.72,"description":"Section 8 empowers the Minister to grant exemptions from Section 7 (importation) on grounds of scientific research or public interest. Section 12 separately empowers the Minister to grant exemptions from Section 7 on the ground that goods are not intended for therapeutic use. These are overlapping exemption regimes with different procedural requirements and different condition-breach consequences (both under s8(3) and s12(2) create deemed offences), but no provision establishes which regime prevails if both could apply, or whether a person must elect one over the other. A person importing for scientific research who also believes the goods have no therapeutic use could invoke either section, with potentially different conditions attached."},{"severity":"medium","section_a":"Section 14(1)","section_b":"Sections 8(3), 9(3), 12(2)","confidence":0.82,"description":"Section 14(1) provides that a person who 'contravenes, or fails to comply with, a provision of this Act' is guilty of an offence. Sections 8(3), 9(3), and 12(2) each deem a person to have 'committed an offence against this Act' for breaching conditions in ministerial instruments — which are not 'provisions of this Act.' This creates two parallel offence-creation mechanisms that are structurally inconsistent: primary offences arise from breaching the Act; deemed offences arise from breaching executive instruments. The deeming provisions are arguably redundant if Section 14(1) is read broadly, or in conflict with it if Section 14(1) is read as exhaustively defining how offences arise."}]}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-substances-act-1953","history":"/api/acts/therapeutic-substances-act-1953/history","analysis":"/api/acts/therapeutic-substances-act-1953/analysis","conflicts":"/api/acts/therapeutic-substances-act-1953/conflicts","importantCases":"/api/acts/therapeutic-substances-act-1953/important-cases","documents":"/api/acts/therapeutic-substances-act-1953/documents"}}